Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551K Buy
175,588
+1,702
+1% +$5.32K 0.08% 233
2026
Q1
$508K Buy
173,886
+3,702
+2% +$10.6K 0.08% 236
2025
Q4
$420K Buy
170,184
+610
+0.4% +$1.45K 0.07% 265
2025
Q3
$378K Buy
169,574
+38,292
+29% +$87.6K 0.05% 301
2025
Q2
$316K Buy
131,282
+21,285
+19% +$51.8K 0.04% 323
2025
Q1
$256K Buy
109,997
+36,736
+50% +$73.5K 0.05% 313
2024
Q4
$136K Sell
73,261
-197
-0.3% -$436 0.02% 353
2024
Q3
$179K Buy
73,458
+10,653
+17% +$23.9K 0.03% 369
2024
Q2
$129K Buy
+62,805
New +$143K 0.03% 314

Other funds holding ABEV

Chicago Trust's ABEV Position: Q2 2026 in Review

Chicago Trust increased its Ambev (ABEV) stake by 0.98% in Q2 2026, buying an estimated $5.32K and bringing the position to 175,588 shares worth $551K. The position accounts for 0.08% of the portfolio, ranked #233.

Chicago Trust first reported a position in ABEV in Q2 2024 and has held it in 9 quarters since. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Chicago Trust held 175,588 shares of Ambev worth $551K as of Q2 2026.
  • Chicago Trust bought 1,702 Ambev shares in Q2 2026, an estimated $5.32K.
  • Ambev made up 0.08% of Chicago Trust's portfolio in Q2 2026, its #233 holding.
  • Chicago Trust first reported a position in Ambev in Q2 2024 and has held it in 9 quarters since.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.